Lagarde Sebastián, María de
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. [artículo] - PLoS One, 2016 - 11(5):e0155842.
Formato Vancouver:
Neukam K, Espinosa N, Collado A, Delgado Fernández M, Jiménez Aguilar P, Rivero Juárez A et al; hEPAtic Study Group. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLoS One. 2016 May 19;11(5):e0155842.
PMID: 27195797
PMC4873169
Contiene 24 referencias
No abstract available
Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. [artículo] - PLoS One, 2016 - 11(5):e0155842.
Formato Vancouver:
Neukam K, Espinosa N, Collado A, Delgado Fernández M, Jiménez Aguilar P, Rivero Juárez A et al; hEPAtic Study Group. Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study. PLoS One. 2016 May 19;11(5):e0155842.
PMID: 27195797
PMC4873169
Contiene 24 referencias
No abstract available
